Literature DB >> 21610193

Dynamic aspects of antibody:oligosaccharide complexes characterized by molecular dynamics simulations and saturation transfer difference nuclear magnetic resonance.

François-Xavier Theillet1, Martin Frank, Brigitte Vulliez-Le Normand, Catherine Simenel, Sylviane Hoos, Alain Chaffotte, Frédéric Bélot, Catherine Guerreiro, Farida Nato, Armelle Phalipon, Laurence A Mulard, Muriel Delepierre.   

Abstract

Carbohydrates are likely to maintain significant conformational flexibility in antibody (Ab):carbohydrate complexes. As demonstrated herein for the protective monoclonal Ab (mAb) F22-4 recognizing the Shigella flexneri 2a O-antigen (O-Ag) and numerous synthetic oligosaccharide fragments thereof, the combination of molecular dynamics simulations and nuclear magnetic resonance saturation transfer difference experiments, supported by physicochemical analysis, allows us to determine the binding epitope and its various contributions to affinity without using any modified oligosaccharides. Moreover, the methods used provide insights into ligand flexibility in the complex, thus enabling a better understanding of the Ab affinities observed for a representative set of synthetic O-Ag fragments. Additionally, these complementary pieces of information give evidence to the ability of the studied mAb to recognize internal as well as terminal epitopes of its cognate polysaccharide antigen. Hence, we show that an appropriate combination of computational and experimental methods provides a basis to explore carbohydrate functional mimicry and receptor binding. The strategy may facilitate the design of either ligands or carbohydrate recognition domains, according to needed improvements of the natural carbohydrate:receptor properties.
© The Author 2011. Published by Oxford University Press. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21610193     DOI: 10.1093/glycob/cwr059

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  4 in total

1.  T cells control the generation of nanomolar-affinity anti-glycan antibodies.

Authors:  Zinaida Polonskaya; Shenglou Deng; Anita Sarkar; Lisa Kain; Marta Comellas-Aragones; Craig S McKay; Katarzyna Kaczanowska; Marie Holt; Ryan McBride; Valle Palomo; Kevin M Self; Seth Taylor; Adriana Irimia; Sanjay R Mehta; Jennifer M Dan; Matthew Brigger; Shane Crotty; Stephen P Schoenberger; James C Paulson; Ian A Wilson; Paul B Savage; M G Finn; Luc Teyton
Journal:  J Clin Invest       Date:  2017-03-13       Impact factor: 14.808

2.  Exploratory N-Protecting Group Manipulation for the Total Synthesis of Zwitterionic Shigella sonnei Oligosaccharides.

Authors:  Debashis Dhara; Laurence A Mulard
Journal:  Chemistry       Date:  2021-03-01       Impact factor: 5.236

3.  The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella.

Authors:  Robert M F van der Put; Carolien Smitsman; Alex de Haan; Martin Hamzink; Hans Timmermans; Joost Uittenbogaard; Janny Westdijk; Michiel Stork; Olga Ophorst; Françoise Thouron; Catherine Guerreiro; Philippe J Sansonetti; Armelle Phalipon; Laurence A Mulard
Journal:  ACS Cent Sci       Date:  2022-03-17       Impact factor: 18.728

4.  Semisynthetic Glycoconjugate Vaccine Candidates against Escherichia coli O25B Induce Functional IgG Antibodies in Mice.

Authors:  Arun Naini; Max Peter Bartetzko; Someswara Rao Sanapala; Felix Broecker; Victoria Wirtz; Marilda P Lisboa; Sharavathi G Parameswarappa; Daniel Knopp; Jessica Przygodda; Matthias Hakelberg; Rosalind Pan; Axay Patel; Laurent Chorro; Arthur Illenberger; Christopher Ponce; Srinivas Kodali; Jacqueline Lypowy; Annaliesa S Anderson; Robert G K Donald; Arne von Bonin; Claney L Pereira
Journal:  JACS Au       Date:  2022-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.